21st Century Health System Resilience: Lessons From the Pandemic on Innovation and Healthy Aging

A new report by the Global Coalition on Aging, 21st Century Health System Resilience: Lessons From the Pandemic on Innovation and Healthy Aging explores the imperative for global health care systems to realign in order to accelerate innovation to meet the challenges – and opportunities – posed by the scientific miracle of longevity and the aging of society. The report was made possible through support from GCOA members and a generous sponsorship from Biogen.

The United Nations’ and World Health Organization’s recently launched Decade of Healthy Ageing is a welcome sign that global policymakers understand the need to make health systems more responsive to the demands of aging societies.

According to the report, “Fully aligning health care systems to a world with 2.1 billion people over age 60 by mid-century will require innovation on a massive scale that can only be achieved by fundamentally re-examining the way countries regulate and reimburse the treatments we will need to care for our growing aging populations.”

Most national health systems were created to provide and pay for acute care – where people are treated for brief but severe periods of illness.  The “disease-cure” model worked when lifespans were short and diseases of aging were more rare.  But it is not designed for a world where billions of people live for decades with steadily worsening conditions like Alzheimer’s disease, osteoporosis and cardiovascular disease.

The report outlines several potential areas of reform:

  • Adopting patient-centered metrics based on functional ability for measuring success in health care.
  • Emphasizing early detection and management of diseases to promote functional ability.
  • Accelerating innovation across drug development.
  • Expanding the discussion to include a broader range of stakeholders beyond traditional health ministries.
  • Adopting a more comprehensive approach to valuing new innovations to account for costs such as informal care often required to handle the diseases of aging.

“Reimagining healthcare systems to meet the needs of healthy aging and an overall healthier society has been proven in times of crisis, such as the COVID-19 pandemic,” said Michael W. Hodin, CEO of GCOA. “Policymakers must recognize the value of these investments and the power that comes with enabling better prevention, diagnosis and treatment. In our aging world, to continually innovate must be a scientific, political and investment priority.”

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

Menopause, the Silver Economy and Workplace Opportunities

As we recognise World Menopause Day, take a moment to consider the economic power, diverse expertise and skills, and incredible societal contributions of the estimated 1.1 billion post-menopausal women worldwide by 2025—a population on-par with China or India, and dwarfing any other country. Indeed, if we want to fuel the vibrant $15 trillion silver economy, societies, governments, and employers must empower older women in the future of work, including solutions that fight stigma and increase workplace support related to menopause.